SlideShare a Scribd company logo
Functional testing in
ambulatory heart failure:
What to test and how
often?
Stuart D. Russell, MD
Professor of Medicine
Disclosures
Research
NIH
Bodyport
Acorai
DSMB – Abbott
Outline
6 minute walk
Cardiopulmonary exercise testing
How developed
Predictor of prognosis
How I use
6 minute walk
27 respiratory patients, 18 HF patients
Each did a total of 6 walks over 3 months
Some were encouraged, some weren’t
Can Med Assoc J 1985;132:919-23
How to perform
2 chairs separated by some distance – usually 20 to 30 meters
Flat corridor without distractions
One observer that gives routine, standardized encouragement
Call out the time every 2 minutes
Patients told to walk at a comfortable pace for as long as they can, feel
free to rest if necessary
Measure distance walked in 6 minutes
6 minute walk
Can Med Assoc J 1985;132:919-23
HF encouraged
Resp encouraged
HF not encouraged
Resp not encouraged
Prognosis in SOLVD
0
2
4
6
8
10
12
Mortality
%
< 300 300-375 375-450 >450
Distance walked (m)
Bittner et al JAMA 1993;270:1702
ESCAPE Prognosis for Mortality - 6 minute walk
0.00
0.05
0.10
0.15
0.20
0.25
0.30
No test 1 to 300 301 to 600 Greater than 600
Six Minute Walk (Feet)
Mortality
(6
Month)
ACC 2005
6 minute walk
Predicts outcomes in outpatients (HF-ACTION JACC 2012;60:2653)
Predicts risk of readmissions (Heart Lung 2017;46:287)
Predicts mortality outcomes after admissions (J Card Fail 2009;15:130)
41% if < 200 m, 19% if > 200 m at 40 months
(ft)
6 min walk vs peak VO2
Lipkin et al Br Med J 1986;292:653
Limitations
Ingle et al (Eur J Heart Failure 2006;8:321)
571 pts with distance 337m
Poor walking distance correlates with …
Age > 75 (O.R. 4.0)
low BMI (O.R. 3.4)
anemia (O.R. 2.8)
HR > 80 (O.R. 2.2)
Female (O.R. 2.0)
ProBNP, self perceived feelings of depression and anxiety also
show dose-response effects
Similar findings in patients without structural heart disease
CPX testing
It used to be a lot more painful….
https://www.pftforum.com/history/gallery/the-douglas-bag/
Coupling of External to Cellular Respiration
Wasserman K. Exercise Gas Exchange in Heart Disease. Future 1996.
CO2 production O2 flow Expired
O2 consumption CO2 flow Inspired
Response: QO2 SV, HR VT, f
Ventilatory pump
Lung muscles
Myasthenia
Guillain-Barre
Chest wall
Kyphoscoliosis
Airways
Interstitial fibrosis
Emphysema
COPD
Cardiac
Heart failure
Pulm edema
Decrease flow
Drugs
Muscle
Muscle disease
Mitochondrial function
Other factors
Altitude
Anemia
VO2 max
Measures maximal reserve of the cardiovascular system
Directly related to cardiac output
Determines peak level of dynamic exercise
Physiologically meaningful
VO2 = cardiac output x (A-V) O2 difference
= HR x SV x (A-V) O2 difference
= HR x EDV-ESV
Determined by …
Type of exercise
Gender
Age
Activity level
Natural endowment
Drugs
16
Clinically Meaningful Improvement for Patients
Correlates with an important increase in the ability to perform daily life
activities
0
10
20
30
40
50
60
70
80
90
100
4 6 8 10 12 14 16 18 20
Oxygen Uptake (ml/kg/min)
Daily
Activities
%
Bedridden
Bed to Chair
Homebound
Mobile with assistance
Independent
Active
Unrestricted
Modified from Jones N, 1988. Clinical Exercise Testing. Saunders.
Peak oxygen consumption and transplant
Prospective eval from 10/86 to 12/89
122 patients referred for transplant
All patients did a metabolic exercise test
Divided into three groups
1 - VO2 < 14 and listed for transplant
2 - VO2 > 14 and felt to be too well for transplant
3 - VO2 < 14, rejected for transplant for
noncardiac reasons
Mancini et al Circ 1991;83:778
Survival post Tx and medical Rx
Mancini et al Circ 1991;83:778
1 Year Survival and Peak VO2
J Am Coll Cardiol 2016; 67:780.
Peak VO2 and prognosis
Complications after major surgery Ann Surg 2010;251:535
AT VO2 > 11.9 had fewer complications
Survival after liver transplant Liver Transpl 2012;18:152
AT VO2 < 9 had all but one die
Outcomes with hypertrophic CM Heart. 2016;102:602-9
Peak VO2 < 15.3 has 14% rate of death/OHT at 5 yrs
Outcomes after LVAD JACC HF 2021;9:758
Findings during CPX testing
Population VO2 Ve MVV DI Sx AT
Normal Nml Nml Nml <0.7 Fatigue Nml
Fit High High High >0.7 SOB High
Pulm limit Low Low Low >0.7 SOB Nml
Cardiac limit Low Low Low/Nml <0.7 SOB Low O2 pulse
Unfit Low Low Nml Nml <0.7 SOB Low OUES
ACC/AHA guidelines for exercise and functional capacity
testing 2022
JACC 2022;679:e263-e421
Assess prognosis
Why is my patient short of breath – heart or lungs or fitness or frailty or BMI
I don’t have a good feel for the true functional capacity of my patient
Lazy, under-reporter (what is the spouse saying?)
Assess pre-operative risk
Evaluate for disability
To determine intensity of exercise training in cardiac rehab

More Related Content

Similar to Functional testing in ambulatory heart failure: What to test and how often?

Update on Pulmonary Arterial Hypertension in Scleroderma
Update on Pulmonary Arterial Hypertension in SclerodermaUpdate on Pulmonary Arterial Hypertension in Scleroderma
Update on Pulmonary Arterial Hypertension in Scleroderma
Scleroderma Foundation of Greater Chicago
 
Heart failure management - role of arni
Heart failure management - role of arniHeart failure management - role of arni
Heart failure management - role of arni
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Post cardiac arrest care in ED
Post cardiac arrest care in EDPost cardiac arrest care in ED
Post cardiac arrest care in ED
kellyam18
 
Channalging Cases in AHF Hypoperfusion
Channalging Cases in AHF HypoperfusionChannalging Cases in AHF Hypoperfusion
Channalging Cases in AHF Hypoperfusion
drucsamal
 
Acute Heart Failure
Acute Heart FailureAcute Heart Failure
Acute Heart Failure
Edgar Hernández
 
Major Case Presentation Final Version
Major Case Presentation Final VersionMajor Case Presentation Final Version
Major Case Presentation Final Version
Mmorshed217
 
Sickle Cell Disease
Sickle Cell DiseaseSickle Cell Disease
Sickle Cell Disease
Usama Ragab
 
C O P D :State of the Art
C O P D :State of the ArtC O P D :State of the Art
C O P D :State of the Art
Dr.Mahmoud Abbas
 
Weaning from mechanical ventilation
Weaning from mechanical ventilationWeaning from mechanical ventilation
Weaning from mechanical ventilation
Sucharita Ray
 
Ufpresenterslides
UfpresenterslidesUfpresenterslides
Ufpresenterslides
hospital
 
NSG 6420_Grand_Round 2_Amougou_Yves
NSG 6420_Grand_Round 2_Amougou_YvesNSG 6420_Grand_Round 2_Amougou_Yves
NSG 6420_Grand_Round 2_Amougou_YvesYves Amougou, BSN RN
 
La enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedadesLa enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedades
Sociedad Española de Cardiología
 
Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians
Sarfraz Saleemi
 
What is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptxWhat is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptxDr.Jose Luis Rodriguez Lopez
 
Cardiorenal syndrome DR Osama EL-Shahat
Cardiorenal syndrome   DR Osama EL-ShahatCardiorenal syndrome   DR Osama EL-Shahat
Cardiorenal syndrome DR Osama EL-ShahatAhmed Albeyaly
 
SYNCOPE..pptx
SYNCOPE..pptxSYNCOPE..pptx
SYNCOPE..pptx
Kush Bhagat
 
PERIPHERAL ARTERY DISEASE.pptx
PERIPHERAL ARTERY DISEASE.pptxPERIPHERAL ARTERY DISEASE.pptx
PERIPHERAL ARTERY DISEASE.pptx
sandeep754264
 
6631948
66319486631948
6631948
vinh nguyen
 
REBOA: Who, What and Why - Deborah Stein
REBOA: Who, What and Why - Deborah SteinREBOA: Who, What and Why - Deborah Stein
REBOA: Who, What and Why - Deborah Stein
SMACC Conference
 
Consensus documents on catheter-based renal denervation - Dr. Josep Redón i Mas
Consensus documents on catheter-based renal denervation - Dr. Josep Redón i MasConsensus documents on catheter-based renal denervation - Dr. Josep Redón i Mas
Consensus documents on catheter-based renal denervation - Dr. Josep Redón i Mas
SHCI - Sección de Hemodinámica y Cardiología Intervencionista
 

Similar to Functional testing in ambulatory heart failure: What to test and how often? (20)

Update on Pulmonary Arterial Hypertension in Scleroderma
Update on Pulmonary Arterial Hypertension in SclerodermaUpdate on Pulmonary Arterial Hypertension in Scleroderma
Update on Pulmonary Arterial Hypertension in Scleroderma
 
Heart failure management - role of arni
Heart failure management - role of arniHeart failure management - role of arni
Heart failure management - role of arni
 
Post cardiac arrest care in ED
Post cardiac arrest care in EDPost cardiac arrest care in ED
Post cardiac arrest care in ED
 
Channalging Cases in AHF Hypoperfusion
Channalging Cases in AHF HypoperfusionChannalging Cases in AHF Hypoperfusion
Channalging Cases in AHF Hypoperfusion
 
Acute Heart Failure
Acute Heart FailureAcute Heart Failure
Acute Heart Failure
 
Major Case Presentation Final Version
Major Case Presentation Final VersionMajor Case Presentation Final Version
Major Case Presentation Final Version
 
Sickle Cell Disease
Sickle Cell DiseaseSickle Cell Disease
Sickle Cell Disease
 
C O P D :State of the Art
C O P D :State of the ArtC O P D :State of the Art
C O P D :State of the Art
 
Weaning from mechanical ventilation
Weaning from mechanical ventilationWeaning from mechanical ventilation
Weaning from mechanical ventilation
 
Ufpresenterslides
UfpresenterslidesUfpresenterslides
Ufpresenterslides
 
NSG 6420_Grand_Round 2_Amougou_Yves
NSG 6420_Grand_Round 2_Amougou_YvesNSG 6420_Grand_Round 2_Amougou_Yves
NSG 6420_Grand_Round 2_Amougou_Yves
 
La enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedadesLa enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedades
 
Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians Pulmonary Hypertension for general physicians
Pulmonary Hypertension for general physicians
 
What is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptxWhat is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptx
 
Cardiorenal syndrome DR Osama EL-Shahat
Cardiorenal syndrome   DR Osama EL-ShahatCardiorenal syndrome   DR Osama EL-Shahat
Cardiorenal syndrome DR Osama EL-Shahat
 
SYNCOPE..pptx
SYNCOPE..pptxSYNCOPE..pptx
SYNCOPE..pptx
 
PERIPHERAL ARTERY DISEASE.pptx
PERIPHERAL ARTERY DISEASE.pptxPERIPHERAL ARTERY DISEASE.pptx
PERIPHERAL ARTERY DISEASE.pptx
 
6631948
66319486631948
6631948
 
REBOA: Who, What and Why - Deborah Stein
REBOA: Who, What and Why - Deborah SteinREBOA: Who, What and Why - Deborah Stein
REBOA: Who, What and Why - Deborah Stein
 
Consensus documents on catheter-based renal denervation - Dr. Josep Redón i Mas
Consensus documents on catheter-based renal denervation - Dr. Josep Redón i MasConsensus documents on catheter-based renal denervation - Dr. Josep Redón i Mas
Consensus documents on catheter-based renal denervation - Dr. Josep Redón i Mas
 

More from Duke Heart

From LVAD to Transplant: State of the Art of Advanced Heart Failure Management
From LVAD to Transplant: State of the Art of Advanced Heart Failure ManagementFrom LVAD to Transplant: State of the Art of Advanced Heart Failure Management
From LVAD to Transplant: State of the Art of Advanced Heart Failure Management
Duke Heart
 
When Everything Fails - Advanced Heart Failure: When to Refer?
When Everything Fails - Advanced Heart Failure: When to Refer?When Everything Fails - Advanced Heart Failure: When to Refer?
When Everything Fails - Advanced Heart Failure: When to Refer?
Duke Heart
 
Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?
Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?
Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?
Duke Heart
 
Obesity Management in Heart Failure: Best Practices to Date
Obesity Management in Heart Failure: Best Practices to DateObesity Management in Heart Failure: Best Practices to Date
Obesity Management in Heart Failure: Best Practices to Date
Duke Heart
 
Cardiometabolic Revolution: Comprehensive Metabolic Care in Heart Failure
Cardiometabolic Revolution: Comprehensive Metabolic Care in Heart FailureCardiometabolic Revolution: Comprehensive Metabolic Care in Heart Failure
Cardiometabolic Revolution: Comprehensive Metabolic Care in Heart Failure
Duke Heart
 
Remote Monitoring: Tracking Congestion & Beyond
Remote Monitoring: Tracking Congestion & BeyondRemote Monitoring: Tracking Congestion & Beyond
Remote Monitoring: Tracking Congestion & Beyond
Duke Heart
 
Congestion Matters! How to Assess It: Old and New Methods
Congestion Matters! How to Assess It: Old and New MethodsCongestion Matters! How to Assess It: Old and New Methods
Congestion Matters! How to Assess It: Old and New Methods
Duke Heart
 
Percutaneous Valve Therapies in Heart Failure
Percutaneous Valve Therapies in Heart FailurePercutaneous Valve Therapies in Heart Failure
Percutaneous Valve Therapies in Heart Failure
Duke Heart
 
Devices in the Management of Chronic Heart Failure
Devices in the Management of Chronic Heart FailureDevices in the Management of Chronic Heart Failure
Devices in the Management of Chronic Heart Failure
Duke Heart
 
Mechanical Circulatory Support Devices in the Management of Cardiogenic Shock
Mechanical Circulatory Support Devices in the Management of Cardiogenic ShockMechanical Circulatory Support Devices in the Management of Cardiogenic Shock
Mechanical Circulatory Support Devices in the Management of Cardiogenic Shock
Duke Heart
 
Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...
Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...
Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...
Duke Heart
 
Multidisciplinary Strategies for Improved Care Coordination in Heart Failure
Multidisciplinary Strategies for Improved Care Coordination in Heart FailureMultidisciplinary Strategies for Improved Care Coordination in Heart Failure
Multidisciplinary Strategies for Improved Care Coordination in Heart Failure
Duke Heart
 
Duke HF - Heart Failure Transitional Care
Duke HF - Heart Failure Transitional CareDuke HF - Heart Failure Transitional Care
Duke HF - Heart Failure Transitional Care
Duke Heart
 
Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?
Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?
Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?
Duke Heart
 
Cardiac Amyloidosis: Diagnostic & Therapeutic Approaches
Cardiac Amyloidosis: Diagnostic & Therapeutic ApproachesCardiac Amyloidosis: Diagnostic & Therapeutic Approaches
Cardiac Amyloidosis: Diagnostic & Therapeutic Approaches
Duke Heart
 
Biomarkers in Ambulatory HF: What to Test and How Often?
Biomarkers in Ambulatory HF: What to Test and How Often?Biomarkers in Ambulatory HF: What to Test and How Often?
Biomarkers in Ambulatory HF: What to Test and How Often?
Duke Heart
 
Treatment for HFpEF-Current State of the Art and Ongoing Trials
Treatment for HFpEF-Current State of the Art and Ongoing TrialsTreatment for HFpEF-Current State of the Art and Ongoing Trials
Treatment for HFpEF-Current State of the Art and Ongoing Trials
Duke Heart
 
Heart Failure with Preserved Ejection Fraction: Diagnostic Updates
Heart Failure with Preserved Ejection Fraction: Diagnostic UpdatesHeart Failure with Preserved Ejection Fraction: Diagnostic Updates
Heart Failure with Preserved Ejection Fraction: Diagnostic Updates
Duke Heart
 
Contemporary Principles for the Management of Heart Failure
Contemporary Principles for the Management of Heart FailureContemporary Principles for the Management of Heart Failure
Contemporary Principles for the Management of Heart Failure
Duke Heart
 
Evolving Pharmacological Treatment Strategies for HFrEF
Evolving Pharmacological Treatment Strategies for HFrEFEvolving Pharmacological Treatment Strategies for HFrEF
Evolving Pharmacological Treatment Strategies for HFrEF
Duke Heart
 

More from Duke Heart (20)

From LVAD to Transplant: State of the Art of Advanced Heart Failure Management
From LVAD to Transplant: State of the Art of Advanced Heart Failure ManagementFrom LVAD to Transplant: State of the Art of Advanced Heart Failure Management
From LVAD to Transplant: State of the Art of Advanced Heart Failure Management
 
When Everything Fails - Advanced Heart Failure: When to Refer?
When Everything Fails - Advanced Heart Failure: When to Refer?When Everything Fails - Advanced Heart Failure: When to Refer?
When Everything Fails - Advanced Heart Failure: When to Refer?
 
Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?
Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?
Navigating Worsening HF Events: What is Worsening HF and How to Recognize It?
 
Obesity Management in Heart Failure: Best Practices to Date
Obesity Management in Heart Failure: Best Practices to DateObesity Management in Heart Failure: Best Practices to Date
Obesity Management in Heart Failure: Best Practices to Date
 
Cardiometabolic Revolution: Comprehensive Metabolic Care in Heart Failure
Cardiometabolic Revolution: Comprehensive Metabolic Care in Heart FailureCardiometabolic Revolution: Comprehensive Metabolic Care in Heart Failure
Cardiometabolic Revolution: Comprehensive Metabolic Care in Heart Failure
 
Remote Monitoring: Tracking Congestion & Beyond
Remote Monitoring: Tracking Congestion & BeyondRemote Monitoring: Tracking Congestion & Beyond
Remote Monitoring: Tracking Congestion & Beyond
 
Congestion Matters! How to Assess It: Old and New Methods
Congestion Matters! How to Assess It: Old and New MethodsCongestion Matters! How to Assess It: Old and New Methods
Congestion Matters! How to Assess It: Old and New Methods
 
Percutaneous Valve Therapies in Heart Failure
Percutaneous Valve Therapies in Heart FailurePercutaneous Valve Therapies in Heart Failure
Percutaneous Valve Therapies in Heart Failure
 
Devices in the Management of Chronic Heart Failure
Devices in the Management of Chronic Heart FailureDevices in the Management of Chronic Heart Failure
Devices in the Management of Chronic Heart Failure
 
Mechanical Circulatory Support Devices in the Management of Cardiogenic Shock
Mechanical Circulatory Support Devices in the Management of Cardiogenic ShockMechanical Circulatory Support Devices in the Management of Cardiogenic Shock
Mechanical Circulatory Support Devices in the Management of Cardiogenic Shock
 
Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...
Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...
Opening Doors to Better Care: Initiating and Sustaining Open Access & Medicat...
 
Multidisciplinary Strategies for Improved Care Coordination in Heart Failure
Multidisciplinary Strategies for Improved Care Coordination in Heart FailureMultidisciplinary Strategies for Improved Care Coordination in Heart Failure
Multidisciplinary Strategies for Improved Care Coordination in Heart Failure
 
Duke HF - Heart Failure Transitional Care
Duke HF - Heart Failure Transitional CareDuke HF - Heart Failure Transitional Care
Duke HF - Heart Failure Transitional Care
 
Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?
Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?
Genetic Cardiomyopathy & Sarcoidosis Clinic: Is There Room to Subspecialize?
 
Cardiac Amyloidosis: Diagnostic & Therapeutic Approaches
Cardiac Amyloidosis: Diagnostic & Therapeutic ApproachesCardiac Amyloidosis: Diagnostic & Therapeutic Approaches
Cardiac Amyloidosis: Diagnostic & Therapeutic Approaches
 
Biomarkers in Ambulatory HF: What to Test and How Often?
Biomarkers in Ambulatory HF: What to Test and How Often?Biomarkers in Ambulatory HF: What to Test and How Often?
Biomarkers in Ambulatory HF: What to Test and How Often?
 
Treatment for HFpEF-Current State of the Art and Ongoing Trials
Treatment for HFpEF-Current State of the Art and Ongoing TrialsTreatment for HFpEF-Current State of the Art and Ongoing Trials
Treatment for HFpEF-Current State of the Art and Ongoing Trials
 
Heart Failure with Preserved Ejection Fraction: Diagnostic Updates
Heart Failure with Preserved Ejection Fraction: Diagnostic UpdatesHeart Failure with Preserved Ejection Fraction: Diagnostic Updates
Heart Failure with Preserved Ejection Fraction: Diagnostic Updates
 
Contemporary Principles for the Management of Heart Failure
Contemporary Principles for the Management of Heart FailureContemporary Principles for the Management of Heart Failure
Contemporary Principles for the Management of Heart Failure
 
Evolving Pharmacological Treatment Strategies for HFrEF
Evolving Pharmacological Treatment Strategies for HFrEFEvolving Pharmacological Treatment Strategies for HFrEF
Evolving Pharmacological Treatment Strategies for HFrEF
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
Sabbu Khatoon
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
Catherine Liao
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
gauripg8
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Catherine Liao
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
Bright Chipili
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
Catherine Liao
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
drtabassum4
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
gauripg8
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
abdeli bhadarva
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
drwaque
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
Ks doctor
 

Recently uploaded (20)

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 

Functional testing in ambulatory heart failure: What to test and how often?

  • 1. Functional testing in ambulatory heart failure: What to test and how often? Stuart D. Russell, MD Professor of Medicine
  • 3. Outline 6 minute walk Cardiopulmonary exercise testing How developed Predictor of prognosis How I use
  • 4. 6 minute walk 27 respiratory patients, 18 HF patients Each did a total of 6 walks over 3 months Some were encouraged, some weren’t Can Med Assoc J 1985;132:919-23
  • 5. How to perform 2 chairs separated by some distance – usually 20 to 30 meters Flat corridor without distractions One observer that gives routine, standardized encouragement Call out the time every 2 minutes Patients told to walk at a comfortable pace for as long as they can, feel free to rest if necessary Measure distance walked in 6 minutes
  • 6. 6 minute walk Can Med Assoc J 1985;132:919-23 HF encouraged Resp encouraged HF not encouraged Resp not encouraged
  • 7. Prognosis in SOLVD 0 2 4 6 8 10 12 Mortality % < 300 300-375 375-450 >450 Distance walked (m) Bittner et al JAMA 1993;270:1702
  • 8. ESCAPE Prognosis for Mortality - 6 minute walk 0.00 0.05 0.10 0.15 0.20 0.25 0.30 No test 1 to 300 301 to 600 Greater than 600 Six Minute Walk (Feet) Mortality (6 Month) ACC 2005
  • 9. 6 minute walk Predicts outcomes in outpatients (HF-ACTION JACC 2012;60:2653) Predicts risk of readmissions (Heart Lung 2017;46:287) Predicts mortality outcomes after admissions (J Card Fail 2009;15:130) 41% if < 200 m, 19% if > 200 m at 40 months (ft)
  • 10. 6 min walk vs peak VO2 Lipkin et al Br Med J 1986;292:653
  • 11. Limitations Ingle et al (Eur J Heart Failure 2006;8:321) 571 pts with distance 337m Poor walking distance correlates with … Age > 75 (O.R. 4.0) low BMI (O.R. 3.4) anemia (O.R. 2.8) HR > 80 (O.R. 2.2) Female (O.R. 2.0) ProBNP, self perceived feelings of depression and anxiety also show dose-response effects Similar findings in patients without structural heart disease
  • 13. It used to be a lot more painful…. https://www.pftforum.com/history/gallery/the-douglas-bag/
  • 14. Coupling of External to Cellular Respiration Wasserman K. Exercise Gas Exchange in Heart Disease. Future 1996. CO2 production O2 flow Expired O2 consumption CO2 flow Inspired Response: QO2 SV, HR VT, f Ventilatory pump Lung muscles Myasthenia Guillain-Barre Chest wall Kyphoscoliosis Airways Interstitial fibrosis Emphysema COPD Cardiac Heart failure Pulm edema Decrease flow Drugs Muscle Muscle disease Mitochondrial function Other factors Altitude Anemia
  • 15. VO2 max Measures maximal reserve of the cardiovascular system Directly related to cardiac output Determines peak level of dynamic exercise Physiologically meaningful VO2 = cardiac output x (A-V) O2 difference = HR x SV x (A-V) O2 difference = HR x EDV-ESV Determined by … Type of exercise Gender Age Activity level Natural endowment Drugs
  • 16. 16 Clinically Meaningful Improvement for Patients Correlates with an important increase in the ability to perform daily life activities 0 10 20 30 40 50 60 70 80 90 100 4 6 8 10 12 14 16 18 20 Oxygen Uptake (ml/kg/min) Daily Activities % Bedridden Bed to Chair Homebound Mobile with assistance Independent Active Unrestricted Modified from Jones N, 1988. Clinical Exercise Testing. Saunders.
  • 17. Peak oxygen consumption and transplant Prospective eval from 10/86 to 12/89 122 patients referred for transplant All patients did a metabolic exercise test Divided into three groups 1 - VO2 < 14 and listed for transplant 2 - VO2 > 14 and felt to be too well for transplant 3 - VO2 < 14, rejected for transplant for noncardiac reasons Mancini et al Circ 1991;83:778
  • 18. Survival post Tx and medical Rx Mancini et al Circ 1991;83:778
  • 19. 1 Year Survival and Peak VO2 J Am Coll Cardiol 2016; 67:780.
  • 20. Peak VO2 and prognosis Complications after major surgery Ann Surg 2010;251:535 AT VO2 > 11.9 had fewer complications Survival after liver transplant Liver Transpl 2012;18:152 AT VO2 < 9 had all but one die Outcomes with hypertrophic CM Heart. 2016;102:602-9 Peak VO2 < 15.3 has 14% rate of death/OHT at 5 yrs Outcomes after LVAD JACC HF 2021;9:758
  • 21. Findings during CPX testing Population VO2 Ve MVV DI Sx AT Normal Nml Nml Nml <0.7 Fatigue Nml Fit High High High >0.7 SOB High Pulm limit Low Low Low >0.7 SOB Nml Cardiac limit Low Low Low/Nml <0.7 SOB Low O2 pulse Unfit Low Low Nml Nml <0.7 SOB Low OUES
  • 22. ACC/AHA guidelines for exercise and functional capacity testing 2022 JACC 2022;679:e263-e421 Assess prognosis Why is my patient short of breath – heart or lungs or fitness or frailty or BMI I don’t have a good feel for the true functional capacity of my patient Lazy, under-reporter (what is the spouse saying?) Assess pre-operative risk Evaluate for disability To determine intensity of exercise training in cardiac rehab